Latest Insider Transactions at Myriad Genetics Inc (MYGN)
This section provides a real-time view of insider transactions for Myriad Genetics Inc (MYGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MYRIAD GENETICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MYRIAD GENETICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 11
2024
|
Paul J Diaz President and CEO |
SELL
Open market or private sale
|
Direct |
15,000
-1.51%
|
$390,000
$26.72 P/Share
|
|
Sep 11
2024
|
Dale Muzzey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,100
-1.91%
|
$54,600
$26.17 P/Share
|
|
Sep 09
2024
|
Heinrich Dreismann Director |
SELL
Open market or private sale
|
Direct |
10,000
-7.6%
|
$270,000
$27.05 P/Share
|
|
Sep 03
2024
|
Jennifer Lynne Fox Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
61,771
+50.0%
|
-
|
|
Sep 03
2024
|
Colleen F Reitan Director |
SELL
Open market or private sale
|
Direct |
46,012
-51.96%
|
$1,242,324
$27.95 P/Share
|
|
Aug 25
2024
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
217
-0.49%
|
$6,076
$28.12 P/Share
|
|
Aug 21
2024
|
Margaret Ancona SVP, Chief of Staff |
SELL
Open market or private sale
|
Direct |
11,538
-12.69%
|
$311,526
$27.82 P/Share
|
|
Aug 19
2024
|
Rashmi Kumar Director |
SELL
Open market or private sale
|
Direct |
7,500
-8.83%
|
$210,000
$28.01 P/Share
|
|
Aug 13
2024
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
73,788
-3.51%
|
$2,066,064
$28.18 P/Share
|
|
Jun 06
2024
|
Daniel Skovronsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,695
+15.43%
|
-
|
|
Jun 06
2024
|
Paul Bisaro Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,695
+28.11%
|
-
|
|
Jun 06
2024
|
S. Louise Phanstiel Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,695
+10.95%
|
-
|
|
Jun 06
2024
|
Colleen F Reitan Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,695
+15.06%
|
-
|
|
Jun 06
2024
|
Rashmi Kumar Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,695
+15.6%
|
-
|
|
Jun 06
2024
|
Lee Nisley Newcomer Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,695
+16.01%
|
-
|
|
Jun 06
2024
|
Heinrich Dreismann Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,695
+10.65%
|
-
|
|
Jun 04
2024
|
Daniel K Spiegelman Director |
SELL
Open market or private sale
|
Direct |
3,788
-10.32%
|
$83,336
$22.05 P/Share
|
|
Jun 03
2024
|
Daniel K Spiegelman Director |
SELL
Open market or private sale
|
Direct |
3,788
-9.35%
|
$83,336
$22.04 P/Share
|
|
May 15
2024
|
Paul J Diaz President and CEO |
SELL
Open market or private sale
|
Direct |
75,000
-6.57%
|
$1,875,000
$25.07 P/Share
|
|
May 14
2024
|
Paul J Diaz President and CEO |
SELL
Open market or private sale
|
Direct |
95,000
-7.69%
|
$2,375,000
$25.21 P/Share
|
|
May 13
2024
|
Paul J Diaz President and CEO |
SELL
Open market or private sale
|
Direct |
57,844
-4.47%
|
$1,446,100
$25.13 P/Share
|
|
May 13
2024
|
Lee Nisley Newcomer Director |
SELL
Open market or private sale
|
Direct |
6,200
-8.51%
|
$155,000
$25.3 P/Share
|
|
Apr 14
2024
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,076
-0.36%
|
$20,444
$19.55 P/Share
|
|
Apr 14
2024
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
940
-0.85%
|
$17,860
$19.55 P/Share
|
|
Apr 06
2024
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
581
-1.29%
|
$11,620
$20.26 P/Share
|
|
Mar 25
2024
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
363
-0.8%
|
$7,623
$21.98 P/Share
|
|
Mar 24
2024
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
45,822
-1.72%
|
$1,008,084
$22.24 P/Share
|
|
Mar 24
2024
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,245
-0.54%
|
$71,390
$22.24 P/Share
|
|
Mar 24
2024
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
943
-0.42%
|
$20,746
$22.24 P/Share
|
|
Mar 24
2024
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,890
-1.08%
|
$63,580
$22.24 P/Share
|
|
Mar 24
2024
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
981
-1.06%
|
$21,582
$22.24 P/Share
|
|
Mar 22
2024
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,202
-1.49%
|
$444,444
$22.24 P/Share
|
|
Mar 22
2024
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,648
-0.54%
|
$36,256
$22.24 P/Share
|
|
Mar 22
2024
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,405
-1.24%
|
$30,910
$22.24 P/Share
|
|
Mar 22
2024
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,685
-1.23%
|
$37,070
$22.24 P/Share
|
|
Mar 22
2024
|
Margaret Ancona SVP, Chief of Staff |
SELL
Payment of exercise price or tax liability
|
Direct |
730
-0.8%
|
$16,060
$22.24 P/Share
|
|
Mar 22
2024
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
363
-0.78%
|
$7,986
$22.24 P/Share
|
|
Mar 22
2024
|
Pamela Wong Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,441
-2.17%
|
$31,702
$22.24 P/Share
|
|
Mar 15
2024
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,686
-1.2%
|
$77,406
$21.16 P/Share
|
|
Mar 15
2024
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,322
-2.85%
|
$69,762
$21.16 P/Share
|
|
Mar 15
2024
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,306
-2.36%
|
$69,426
$21.16 P/Share
|
|
Mar 15
2024
|
Margaret Ancona SVP, Chief of Staff |
SELL
Payment of exercise price or tax liability
|
Direct |
1,585
-1.7%
|
$33,285
$21.16 P/Share
|
|
Mar 15
2024
|
Pamela Wong Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,568
-3.72%
|
$53,928
$21.16 P/Share
|
|
Mar 15
2024
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
30,610
-2.2%
|
$642,810
$21.16 P/Share
|
|
Mar 14
2024
|
Scott J. Leffler Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,095
+21.95%
|
-
|
|
Mar 14
2024
|
Samraat S. Raha Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
64,494
+17.65%
|
-
|
|
Mar 14
2024
|
Mark Verratti Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
58,631
+15.98%
|
-
|
|
Mar 14
2024
|
Dale Muzzey Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,250
+29.67%
|
-
|
|
Mar 14
2024
|
Shereen Solaiman Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,042
+42.38%
|
-
|
|
Mar 14
2024
|
Kevin Richard Haas Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,178
+20.08%
|
-
|